1. MULTIPLE MYELOMA MINIMAL RESIDUAL DISEASE - INVIMA Registration 320718ceba0c8bfdc86bb0ce9b2a6970
Access comprehensive regulatory information for 1. MULTIPLE MYELOMA MINIMAL RESIDUAL DISEASE (1. MULTIPLE MYELOMA MINIMAL RESIDUAL DISEASE) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 320718ceba0c8bfdc86bb0ce9b2a6970 and manufactured by BECTON DICKINSON DE COLOMBIA LTDA. The device was registered on June 07, 2033.
This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
LOS REACTIVOS AMPARADOS EN ESTE REGISTRO SANITARIO, SON REACTIVOS PARA LA DETECCIÓN Y/O CUANTIFICACIÓN EN MUESTRAS_x000D_ BIOLÓGICAS DE ORIGEN HUMANO, PARA LA IDENTIFICACIÓN Y ENUMERACIÓN DE CÉLULAS O POBLACIONES CELULARES, QUE EXPRESAN UNA_x000D_ DETERMINADA DIANA O ANTÍGENO PARA LA DETERMINACIÓN DE UNA CONDICIÓN PARTICULAR. SU PLATAFORMA TECNOLÓGICA ES LA CITOMETRÍA_x000D_ DE FLUJO.
THE REAGENTS COVERED BY THIS HEALTH REGISTRY ARE REAGENTS FOR DETECTION AND/OR QUANTIFICATION IN MUESTRAS_x000D_ BIOLOGICAL DATA OF HUMAN ORIGIN, FOR THE IDENTIFICATION AND ENUMERATION OF CELLS OR CELL POPULATIONS, WHICH EXPRESS UNA_x000D_ A PARTICULAR TARGET OR ANTIGEN FOR THE DETERMINATION OF A PARTICULAR CONDITION. ITS TECHNOLOGY PLATFORM IS THE CITOMETRÍA_x000D_ FLOW.